News
20h
News-Medical.Net on MSNSemaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial showsA phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
3d
New Scientist on MSNDrugs like Wegovy can be effective at treating fatty liver diseaseSemaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results